KOCAA
PTCT icon

Knights of Columbus Asset Advisors’s PTC Therapeutics PTCT Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,693
Closed -$457K – 419
2024
Q1 		$457K Sell
15,693
-43,731
-74% -$1.22M 0.03% 279
2023
Q4 		$1.64M Buy
59,424
+30,309
+104% +$693K 0.11% 239
2023
Q3 		$652K Buy
29,115
+692
+2% +$25.7K 0.06% 258
2023
Q2 		$1.16M Buy
28,423
+61
+0.2% +$2.98K 0.1% 237
2023
Q1 		$1.37M Buy
28,362
+218
+0.8% +$9.96K 0.14% 220
2022
Q4 		$1.07M Sell
28,144
-421
-1% -$17.5K 0.11% 222
2022
Q3 		$1.43M Buy
28,565
+3,488
+14% +$171K 0.15% 202
2022
Q2 		$1M Buy
25,077
+100
+0.4% +$3.51K 0.1% 222
2022
Q1 		$932K Buy
24,977
+320
+1% +$12.3K 0.08% 231
2021
Q4 		$982K Buy
24,657
+437
+2% +$16.7K 0.08% 228
2021
Q3 		$901K Buy
24,220
+245
+1% +$10.1K 0.08% 228
2021
Q2 		$1.01M Buy
23,975
+83
+0.3% +$3.56K 0.09% 226
2021
Q1 		$1.13M Sell
23,892
-307
-1% -$18.2K 0.11% 238
2020
Q4 		$1.48M Sell
24,199
-22
-0.1% -$1.3K 0.16% 229
2020
Q3 		$1.13M Sell
24,221
-3,590
-13% -$177K 0.14% 224
2020
Q2 		$1.41M Buy
27,811
+3,347
+14% +$164K 0.17% 190
2020
Q1 		$1.09M Sell
24,464
-13,617
-36% -$686K 0.14% 230
2019
Q4 		$1.83M Buy
+38,081
New +$1.62M 0.16% 227

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Knights of Columbus Asset Advisors's PTCT Position: Q2 2024 in Review

Knights of Columbus Asset Advisors sold out of PTC Therapeutics (PTCT) in Q2 2024, closing a stake of 15,693 shares — an estimated $457K sold.

Knights of Columbus Asset Advisors first reported a position in PTCT in Q4 2019 and held it in 18 quarters. The position peaked at $1.83M in Q4 2019. 199 funds tracked by Wall St. Rank hold PTCT as of Q2 2024.

  • Knights of Columbus Asset Advisors reported no remaining PTC Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 15,693 PTC Therapeutics shares in Q2 2024, an estimated $457K.
  • Knights of Columbus Asset Advisors first reported a position in PTC Therapeutics in Q4 2019 and held it in 18 quarters.
  • Knights of Columbus Asset Advisors's PTC Therapeutics position peaked at $1.83M in Q4 2019.
  • 199 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2024.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2024, filed 30 Jul 2024.